398
Participants
Start Date
December 31, 2010
Primary Completion Date
December 31, 2013
Study Completion Date
December 31, 2013
tiotropium Respimat low dose
IMP
placebo Respimat
placebo representing comparator
tiotropium Respimat high dose
IMP
205.444.01004 Boehringer Ingelheim Investigational Site, Plymouth
205.444.01005 Boehringer Ingelheim Investigational Site, Columbia
205.444.01001 Boehringer Ingelheim Investigational Site, Cincinnati
205.444.01014 Boehringer Ingelheim Investigational Site, Oklahoma City
205.444.01002 Boehringer Ingelheim Investigational Site, Charleston
205.444.01012 Boehringer Ingelheim Investigational Site, Charleston
205.444.01013 Boehringer Ingelheim Investigational Site, El Paso
205.444.01003 Boehringer Ingelheim Investigational Site, South Burlington
205.444.56002 Boehringer Ingelheim Investigational Site, Santiago
205.444.56001 Boehringer Ingelheim Investigational Site, Viña del Mar
205.444.56003 Boehringer Ingelheim Investigational Site, Viña del Mar
205.444.49007 Boehringer Ingelheim Investigational Site, Berlin
205.444.49008 Boehringer Ingelheim Investigational Site, Berlin
205.444.49001 Boehringer Ingelheim Investigational Site, Bochum
205.444.49003 Boehringer Ingelheim Investigational Site, Ettenheim
205.444.49006 Boehringer Ingelheim Investigational Site, Koblenz
205.444.49005 Boehringer Ingelheim Investigational Site, Rosenheim
205.444.36007 Boehringer Ingelheim Investigational Site, Ajka
205.444.36005 Boehringer Ingelheim Investigational Site, Budapest
205.444.36008 Boehringer Ingelheim Investigational Site, Budapest
205.444.36006 Boehringer Ingelheim Investigational Site, Kaposvár
205.444.36001 Boehringer Ingelheim Investigational Site, Miskolc
205.444.36002 Boehringer Ingelheim Investigational Site, Mosdós
205.444.36003 Boehringer Ingelheim Investigational Site, Szeged
205.444.36004 Boehringer Ingelheim Investigational Site, Szigetbecse
205.444.39001 Boehringer Ingelheim Investigational Site, Ancona
205.444.39003 Boehringer Ingelheim Investigational Site, Bolzano
205.444.39002 Boehringer Ingelheim Investigational Site, Verona
205.444.37101 Boehringer Ingelheim Investigational Site, Baldone
205.444.37107 Boehringer Ingelheim Investigational Site, Balvi
205.444.37102 Boehringer Ingelheim Investigational Site, Ogre
205.444.37105 Boehringer Ingelheim Investigational Site, Rēzekne
205.444.37106 Boehringer Ingelheim Investigational Site, Riga
205.444.37103 Boehringer Ingelheim Investigational Site, Talsi
205.444.37104 Boehringer Ingelheim Investigational Site, Tukums
205.444.52002 Boehringer Ingelheim Investigational Site, Guadalajara
205.444.52001 Boehringer Ingelheim Investigational Site, Hermosillo
205.444.52003 Boehringer Ingelheim Investigational Site, Monterrey
205.444.70003 Boehringer Ingelheim Investigational Site, Moscow
205.444.70002 Boehringer Ingelheim Investigational Site, Saint Petersburg
205.444.70004 Boehringer Ingelheim Investigational Site, Saint Petersburg
205.444.70005 Boehringer Ingelheim Investigational Site, Saint Petersburg
205.444.70006 Boehringer Ingelheim Investigational Site, Saint Petersburg
205.444.70001 Boehringer Ingelheim Investigational Site, Yaroslavl
205.444.42104 Boehringer Ingelheim Investigational Site, Košice
205.444.42106 Boehringer Ingelheim Investigational Site, Martin
205.444.42101 Boehringer Ingelheim Investigational Site, Nitra
205.444.42105 Boehringer Ingelheim Investigational Site, Rožňava
205.444.82003 Boehringer Ingelheim Investigational Site, Guri-si
205.444.82006 Boehringer Ingelheim Investigational Site, Incheon
205.444.82001 Boehringer Ingelheim Investigational Site, Seoul
205.444.82004 Boehringer Ingelheim Investigational Site, Seoul
205.444.34007 Boehringer Ingelheim Investigational Site, Esplugues Del Llobregat
205.444.34001 Boehringer Ingelheim Investigational Site, Madrid
205.444.34004 Boehringer Ingelheim Investigational Site, Majadahonda (Madrid)
205.444.34005 Boehringer Ingelheim Investigational Site, Marbella
205.444.34006 Boehringer Ingelheim Investigational Site, Sabdadell
205.444.34008 Boehringer Ingelheim Investigational Site, Valencia
205.444.38008 Boehringer Ingelheim Investigational Site, Dnipropetrovsk
205.444.38002 Boehringer Ingelheim Investigational Site, Donetsk
205.444.38005 Boehringer Ingelheim Investigational Site, Kharkiv
205.444.38003 Boehringer Ingelheim Investigational Site, Kiev
205.444.38004 Boehringer Ingelheim Investigational Site, Kiev
205.444.38001 Boehringer Ingelheim Investigational Site, Lviv
205.444.38010 Boehringer Ingelheim Investigational Site, Zaporizhya
205.444.38009 Boehringer Ingelheim Investigational Site, Zaporizhzhya
Lead Sponsor
Collaborators (1)
Pfizer
INDUSTRY
Boehringer Ingelheim
INDUSTRY